EQUICLIN
EQUICLIN helps sponsors improve trial diversity and health outcomes by centering underrepresented populations. It uses AI-enabled technology to identify and activate clinical research sites and design recruitment strategies. The company operates in the B2B clinical research category, supporting Real-World Data (RWD) and Real-World Evidence (RWE) generation and integrates with sponsor data workflows. With partners across Africa, Europe, Asia and the Americas, it supports Phase 4 trials and post-marketing safety monitoring. The focus is on increasing access, choice and equity in health research.
EQUICLIN
EQUICLIN helps sponsors improve trial diversity and health outcomes by centering underrepresented populations. It uses AI-enabled technology to identify and activate clinical research sites and design recruitment strategies. The company operates in the B2B clinical research category, supporting Real-World Data (RWD) and Real-World Evidence (RWE) generation and integrates with sponsor data workflows. With partners across Africa, Europe, Asia and the Americas, it supports Phase 4 trials and post-marketing safety monitoring. The focus is on increasing access, choice and equity in health research.